Treatment advances have dramatically increased the cure rate for acute lymphoblastic leukemia (ALL), the most common diagnosed cancer in children, from less than 10% in the 1960’s to more than 80%.
But even in those children who are cured, the response to treatment varies from patient to patient. For some, just a couple of weeks [...]

Tags: ALL, JAMA, leukemia, minimal residual disease